It has been traditionally recommended that candidates for vascular surgery receive noninvasive stress perfusion testing risk stratification to help decide which patients may benefit from coronary artery revascularization. Recent clinical trials have contested the efficacy of revascularization in this population as well as the information yield of noninvasive testing. This article reviews a number of these studies that are likely to change our beliefs regarding testing and subsequent interventions as well as evolving role of medical therapy in patients undergoing vascular surgery.
ManganoDTGoldmanL. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333:1750-1756.
3.
BrownerWSLiJManganoDT. In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 1992;268:228-232.
4.
ManganoDTBrownerWSHollenbergMLiJTateoIM. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 1992;268:233-239.
5.
ManganoDTBrownerWSHollenbergMLondonMJTubauJFTateoIM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323:1781-1788.
6.
BauerSMCayneNSVeithFJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg. 2010;51:242-251.
7.
HertzerNRYoungJRKramerJR. Routine coronary angiography prior to elective aortic reconstruction: results of selective myocardial revascularization in patients with peripheral vascular disease. Arch Surg. 1979;114:1336-1344.
8.
StegPGBhattDLWilsonPW; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-1206.
9.
DawoodMMGutpaDKSouthernJWaliaAAtkinsonJBEagleKA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57:37-44.
10.
EagleKARihalCSFosterEDGershBJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study.Circulation. 1997;96(6):1882-7.
11.
FosterEDDavisKBCarpenterJAAbeleSFrayD. Risk of noncardiac operation in patients with defined coronary disease: The Coronary Artery Surgery Study (CASS) Registry experience. Ann Thorac Surg. 1986;41:42-50.
12.
LeeTHMarcantonioERMangioneCM. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
13.
FleisherLABeckmanJABrownKA. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116:e418-e499.
14.
HertzerNRYoungJRBevenEG. Late results of coronary bypass in patients with peripheral vascular disease. II. Five-year survival according to sex, hypertension, and diabetes. Cleve Clin J Med. 1987;54:15-23.
15.
McFallsEOWardHBMoritzTE. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-2804.
16.
BoersmaEPoldermansDBaxJJ. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA. 2001;285:1865-1873.
17.
PoldermansDBaxJJSchoutenO. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?J Am Coll Cardiol. 2006;48: 964-969.
18.
DevereauxPJGoldmanLCookDJGilbertKLeslieKGuyattGH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627-634.
19.
ParkerSDBreslowMJFrankSM. Catecholamine and cortisol responses to lower extremity revascularization: correlation with outcome variables. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Crit Care Med. 1995;23:1954-1961.
EllisSGHertzerNRYoungJRBrenerS. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol. 1996;77:1126-1128.
23.
PoldermansDBoersmaEBaxJJ. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol. 2001;88:1413-1414, A6.
24.
CrisbyMNordin-FredrikssonGShahPKYanoJZhuJNilssonJ. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926-933.
25.
MahmoudiMCurzenNGallagherPJ. Atherogenesis: the role of inflammation and infection. Histopathology. 2007;50:535-546.
26.
AuerJLammGEberB. Coronary revascularization before vascular surgery. N Engl J Med. 2005;352:1492-1495.
27.
BackMRLeoFCuthbertsonDJohnsonBLShamesmdMLBandykDF. Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg. 2004;40:752-760.
28.
LandesbergGMosseriMFleisherLA. Coronary revascularization before vascular surgery. N Engl J Med. 2005;352:1492-1495.
29.
PoldermansDSchoutenOVidakovicR. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49:1763-1769.
30.
SchoutenOvan DomburgRTBaxJJ. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol. 2007;49:122-124.
31.
PoldermansDBoersmaEBaxJJ. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341: 1789-1794.
32.
SchoutenOBoersmaEHoeksSE. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980-989.
33.
DevereauxPJYangHYusufS. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839-1847.
34.
LindenauerPKPekowPWangKMamidiDKGutierrezBBenjaminEM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361.
35.
FletcherGFBaladyGFroelicherVFHartleyLHHaskellWLPollockML. Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1995;91:580-615.
36.
HlatkyMABoineauREHigginbothamMB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64: 651-654.
37.
EagleKABergerPBCalkinsH. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105:1257-1267.
38.
PoldermansDBaxJJKertaiMD. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848-1851.
39.
DurazzoAEMachadoFSIkeokaDT. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967-975.
40.
SchoutenOHoeksSEWeltenGM. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol. 2007;100:316-320.
41.
HalmEABrownerWSTubauJFTateoIMManganoDT. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med. 1996;125:433-441.
